Danazol and Aplastic anemia - a phase IV clinical study of FDA data

Summary:

Aplastic anemia is reported as a side effect among people who take Danazol (danazol), especially for people who are male, 60+ old, also take Promacta, and have Idiopathic thrombocytopenic purpura.

The phase IV clinical study analyzes which people have Aplastic anemia when taking Danazol. It is created by eHealthMe based on reports of 3,687 people who have side effects when taking Danazol from the FDA, and is updated regularly.

What is Danazol?

Danazol has active ingredients of danazol. It is often used in hereditary angioedema. eHealthMe is studying from 3,716 Danazol users. Check the latest studies of Danazol.

What is Aplastic anemia?

Aplastic anemia is found to be associated with 626 drugs and 879 conditions by eHealthMe. Check the latest studies of Aplastic anemia.

On Jul, 11, 2026

3,687 people reported to have side effects when taking Danazol.
Among them, 25 people (0.68%) have Aplastic anemia.

Among these 25 people:

What is the gender of people who have Aplastic anemia when taking Danazol? *

female: 45.83 %
male: 54.17 %

What is the age of people who have Aplastic anemia when taking Danazol? *

What are other drugs people take besides Danazol? *

What are other side effects people have besides Aplastic anemia? *

Thrombocytopenia (decrease of platelets in blood): 13 people, 52.00%
Anaemia (lack of blood): 8 people, 32.00%
Fever: 7 people, 28.00%
Disease Progression: 7 people, 28.00%
White Blood Cell Count Decreased: 5 people, 20.00%
Drug Ineffective: 5 people, 20.00%
Chest Pain: 4 people, 16.00%
Hyperhidrosis (abnormally increased sweating): 4 people, 16.00%
Listeriosis (a food borne illness caused by listeria monocytogenes, bacteria found in soil and water): 4 people, 16.00%
Fatigue (feeling of tiredness): 4 people, 16.00%

What are the existing conditions these people have? *

Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 8 people, 32.00%
Spinal Compression Fracture (fracture due to spinal compression on bone): 4 people, 16.00%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 4 people, 16.00%
Osteoporosis (bones weak and more likely to break): 4 people, 16.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 16.00%
Thrombocytopenia (decrease of platelets in blood): 3 people, 12.00%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 12.00%
Haemosiderosis (general increase in tissue iron stores without associated tissue damage): 2 people, 8.00%
Diabetes: 1 person, 4.00%
Bone Marrow Conditioning Regimen: 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Danazol and have Aplastic anemia?

- Check whether Aplastic anemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Danazol:

Danazol (3,716 reports)

Aplastic anemia treatments and more:

Aplastic anemia (14,870 reports)

Browse all side effects of Danazol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Aplastic anemia:

Aplastic anemia (626 drugs)

Browse all the conditions that are associated with Aplastic anemia:

Aplastic anemia (879 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on danazol (the active ingredients of Danazol) and Danazol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.